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The global population 
of SARS‑CoV‑2 is composed of six 
major subtypes
Ivair José Morais1, Richard Costa Polveiro2, Gabriel Medeiros Souza3, Daniel Inserra Bortolin3, 
Flávio Tetsuo Sassaki4 & Alison Talis Martins Lima3*
The World Health Organization characterized COVID‑19 as a pandemic in March 2020, the second 
pandemic of the twenty‑first century. Expanding virus populations, such as that of SARS‑CoV‑2, 
accumulate a number of narrowly shared polymorphisms, imposing a confounding effect on 
traditional clustering methods. In this context, approaches that reduce the complexity of the 
sequence space occupied by the SARS‑CoV‑2 population are necessary for robust clustering. Here, we 
propose subdividing the global SARS‑CoV‑2 population into six well‑defined subtypes and 10 poorly 
represented genotypes named tentative subtypes by focusing on the widely shared polymorphisms 
in nonstructural (nsp3, nsp4, nsp6, nsp12, nsp13 and nsp14) cistrons and structural (spike and 
nucleocapsid) and accessory (ORF8) genes. The six subtypes and the additional genotypes showed 
amino acid replacements that might have phenotypic implications. Notably, three mutations (one 
of them in the Spike protein) were responsible for the geographical segregation of subtypes. We 
hypothesize that the virus subtypes detected in this study are records of the early stages of SARS‑
CoV‑2 diversification that were randomly sampled to compose the virus populations around the world. 
The genetic structure determined for the SARS‑CoV‑2 population provides substantial guidelines for 
maximizing the effectiveness of trials for testing candidate vaccines or drugs.
In December 2019, a local pneumonia outbreak of initially unknown aetiology was detected in Wuhan (Hubei, 
China) and quickly determined to be caused by a novel  coronavirus1, named severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2)2, with the disease referred to as COVID-193. SARS-CoV-2 belongs to family Coro-
naviridae, genus Betacoronavirus, which comprises enveloped, positive-stranded RNA viruses of  vertebrates2. 
Two-thirds of SARS-CoV genomes are covered by ORF1ab, which encodes a large polypeptide that is cleaved into 
16 nonstructural proteins (NSPs) involved in replication-transcription in vesicles from endoplasmic reticulum 
(ER)-derived  membranes4,5. The last third of the virus genome encodes four essential structural proteins, namely, 
Spike (S), Envelope (E), Membrane (M), and Nucleocapsid (N), and several accessory proteins that interfere 
with the host innate immune  response6.
Populations of RNA viruses evolve rapidly due to their large sizes, short generation times, and high mutation 
rates, the last of which is a consequence of RNA-dependent RNA polymerase (RdRP), which lacks proofreading 
 activity7. In fact, virus populations are composed of a broad spectrum of closely related genetic variants resem-
bling one or more master  sequences8–10. Mutation rates inferred for SARS-CoVs are considered  moderate11,12 
due to independent proofreading  activity13. However, the large SARS-CoV genomes (from 27 to 31 kb)14 allow 
efficient exploration of the sequence  space15. To better understand the diversification of SARS-CoV-2 genomes 
during the pandemic (from December 2019 to March 25, 2020), we applied a simple but robust approach to 
reduce the complexity of the sequence space occupied by the virus population by detecting its widely shared 
polymorphisms.
A total of 767 SARS-CoV-2 genomes with high sequencing coverage obtained from GISAID (https ://www.
gisai d.org/) and GenBank were clustered into 593 haplotypes (Table S1). We conducted a fine-scale sequence 
variation analysis of the 593 genome-containing alignment by calculating nucleotide diversity (π) using slid-
ing window and step sizes of 300 and 20 nucleotides, respectively (multiple sequence alignments generated in 
this study are available from the authors upon request). Such an approach allows the identification of genomic 
regions with increased genetic variation from polymorphic sites harbouring two or more distinct nucleotide 
OPEN
1Departamento de Fitopatologia, Universidade de Brasília, Brasília, DF 70910-900, Brazil. 2Departamento de 
Veterinária, Universidade Federal de Viçosa, Viçosa, MG 36570-900, Brazil. 3Instituto de Ciências Agrárias, 
Universidade Federal de Uberlândia, Uberlândia, MG 38410-337, Brazil. 4Instituto de Biotecnologia, Universidade 
Federal de Uberlândia, Monte Carmelo, MG 38500-000, Brazil. *email: atmlima@ufu.br
2
Vol:.(1234567890)
Scientific Reports |        (2020) 10:18289  | https://doi.org/10.1038/s41598-020-74050-8
www.nature.com/scientificreports/
bases. Noticeably, one or more large clusters of closely related sequences, when analysed by this approach, 
show locally increased nucleotide diversity. We observed contrasting distributions of genetic variation across 
the full-length genomes of SARS-CoV-2 (Fig. 1), with eight segments (S) showing increased genetic variation, 
arbitrarily defined as nucleotide (nt) segments with π ≥ 0.001. Seven out of eight segments were approximately 
280 nucleotides (nt) in length, corresponding approximately to the size of a single sliding window, except S10, 
whose length was equivalent to two sliding windows (600 nt). To further investigate the diversification of seg-
ments with contrasting degrees of genetic variability, we constructed maximum likelihood (ML) phylogenetic 
trees and analysed the diversification patterns of eight segments with higher genetic variation (S2, 4, 6, 8, 10, 12, 
14 and 16) and nine with lower genetic variation (S1, 3, 5, 7, 9, 11, 13, 15 and 17).
Although the data set was composed of hundreds of SARS-CoV-2 genomes sampled from around the world, 
in the S2-based tree, we observed two clusters (Fig. S1a). Notably, each cluster was composed of very closely 
related, if not identical, sequences. Therefore, the increased degree of genetic variation at S2 was a result of inter-
cluster sequence comparisons. Similar results were obtained for the other seven ML trees based on segments 
with increased genetic variation (Fig. S1b–h). In contrast, the ML trees based on segments with lower genetic 
variation did not show a consistent number of well-defined clusters (Fig. S2).
We mapped the polymorphic sites in segments with increased genetic variation responsible for the segregation 
of ML trees into two well-defined clusters (Table 1). Only a few (from one to three) nt positions with polymor-
phisms shared by a number of SARS-CoV-2 genomes could be identified within each segment with increased 
genetic variation. These polymorphisms were henceforth referred to as ‘widely shared polymorphisms’ (WSPs), 
while the remaining nt positions in virus genomes were designated as ‘non-widely shared polymorphisms’ 
(nWSPs).
We compared the topologies of the seventeen ML trees (Figs. S1 and S2) by computing their pairwise distances 
followed by a multivariate analysis to group similar trees (Fig. 2). The seventeen trees were subdivided into seven 
groups, with the largest including nWSP-containing segment-based trees (S1, 3, 5, 7, 9, 11, 13, 15 and 17; Fig. 2, 
Group 7). Given the low genetic variation in these segments, the resulting trees were poorly resolved, suggesting 
that such regions represent a wide mutant spectrum of narrowly shared polymorphisms. It is important to note 
that there are minor clusters in nWSP-containing segment-based ML trees, e.g., in those for S1, S13 and S17. 
This is a consequence of our conservative threshold, as we focused on segments with π ≥ 0.001. S1, S13 and S17 
also show locally increased genetic variation with π values higher than 0.0005 but lower than 0.001, for example, 
stretches 916–1196, 1436–1536 (within S1), 25,430–25,720 (S13), 29,565–29,637 (S17) (Fig. 1).
Figure 1.  Mean pairwise number of nucleotide differences per site (nucleotide diversity, π) calculated using a 
sliding window of 300 nucleotides across the multiple sequence alignment for full-length genomes of SARS-
CoV-2. The red dashed line at π = 0.001 represents an arbitrary threshold used to subdivide the segments (S) 
with higher (S2, 4, 6, 8, 10, 12, 14 and 16) and lower (S1, 3, 5, 7, 9, 11, 13,15 and 17) levels of genetic variation. 
The SARS-CoV-2 genome organization is represented on top of the plot.
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Table 1.  Characterization of the WSPs detected in genomes of SARS-CoV-2. a Relative to the multiple 
sequence alignment constructed for full-length genomes. b Widely shared polymorphism (WSP) positions are 
relative to the reference genome (GISAID accession ID: EPI_ISL_402124).
Segment ID
Segment  positiona 
(begin–end) WSPsb
nt mutation (# 
isolates)
Position in the 
codon #codon Amino acid
S2 2899–3179 nsp3-[3,037] U (184)/C (409) Third 106 Phenylalanine/Pheny-lalanine
S4 8639–8919 nsp4-[8,782] U (183)/C (410) Third 76 Serine/Serine
S6 10,959–11,219 nsp6-[11,083] C (1)/U (99)/G (493) Third 37 Phenylalanine/Pheny-lalanine/Leucine
S8 14,259–14,539 nsp12-[14,408] U (184)/C (409) Second 323 Leucine/Proline
S10 17,600–18,200
nsp13-[17,747] U (101)/C (492) Second 504 Leucine/Proline
nsp13-[17,858] G (101)/A (492) Second 541 Cysteine/Tyrosine
nsp14-[18,060] U (105)/C (488) Third 7 Leucine/Leucine
S12 23,270–23,550 S-[23,403] G (185)/A (408) Second 614 Glycine/Aspartate
S14 28,004–28,285 ORF8-[28,144] C (184)/U (409) Second 84 Serine/Leucine
S16 28,745–29,025
N-[28,881] A (60)/G (533) Second
203 Lysine/Arginine
N-[28,882] A (60)/G (533) Third
N-[28,883] C (60)/G (533) First 204 Glycine/Arginine
Figure 2.  Multidimensional scaling (MDS) visualization of tree distances based on the Kendall-Colijn metric 
(λ = 0). The seventeen ML trees (each with 593 tips) are represented as dots, and groups of trees showing similar 
topologies are indicated by the same colour. The WSP-containing segment-based trees formed six groups: the 
first group comprised S2, S8 and S12 (indicated in blue), while the other five were represented by single trees 
(groups 2–6 indicated in red, green, orange, purple and brown, respectively). All nWSP-containing segment-
based ML trees formed a single group, indicated in pink.
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The S2-, S8- and S12-based ML trees (Fig. 2, Group 1) were considerably congruent, and the nucleotides at 
their WSPs tended to co-segregate (UUG or CCA, Table 1), which resulted in two major subtypes of SARS-CoV-2 
(Figs. S1a, 1d and 1f). Reciprocally, the incongruency among the S4-, 6-, 10-, 14- and 16-based trees (Fig. 2, 
Groups 2–6) suggests the segregation of nucleotides at their WSPs, which increases the possible combinations 
of virus genotypes.
Therefore, our approach reduced the complexity of the sequence space occupied by the SARS-CoV-2 genomes 
and provided a robust clustering solution based on the combination of 12 WSPs (Table 1) to barcode the major 
viral genotypes spread worldwide (Table 2 and Table S2). The global population of SARS-CoV-2 is structured into 
six major subtypes (I–VI), comprising 578 of 593 (approximately 97.5%) isolates analysed in this study. Subtype 
I (N = 132) was represented by the combination of the most frequent nucleotides at all WSPs, i.e., the canonical 
genotype CCG CCA CAU GGG . The SARS-CoV-2 reference genome (GISAID accession ID: EPI_ISL_402124, 
GenBank accession: MN908947) is a representative member of this subtype. Subtype IV (N = 91) was represented 
by the combination of the most frequent nucleotides at eleven of 12 WSPs (CCUCCA CAU GGG ; the most 
frequent nucleotides at each WSP are highlighted in bold and underlined). Subtypes V (N = 74, CUGCC ACA 
CGGG ), II (N = 122, UCGUCAC GUGGG ), III (N = 101, CUGCUGU ACGGG ) and VI (N = 58, UCGUCAC 
GUAAC) were represented by the combination of the most frequent nucleotides at ten, nine, seven and six of 
12 WSPs, respectively.
It is important to note the intrinsic wide geographical coverage of these subtypes, since they were sampled 
from distinct countries or even continents, which describes the viral spread at a global scale (Fig. 3). A dynamic 
map of the spatial–temporal spread of isolates of the six subtypes of SARS-CoV-2 is available as a Microreact 
project (https ://micro react .org/proje ct/f25A3 jAvE5 TjzxA f38UC Eq). Another important feature is that they are 
predominantly composed of genomes sequenced from original samples, minimizing any mutational bias due 
to in vitro virus replication (Fig. 4). Studies on the mutational dynamics of SARS-CoV-2 in cell culture have 
not been conducted thus far; however, previous studies on the mutational dynamics of SARS-CoV indicated a 
negligible mutation frequency after five serial Vero-E6 cell  passages16. 
Ten additional viral genotypes were poorly represented and, therefore, referred to as tentative subtypes 
(Table 2). This category of tentative subtypes would be useful due to the continuous addition of genomes to 
public databases, where more representative members might be sampled from a wider geographical context. 
This conservative proposal would keep the inclusive nature of our clustering method, being able to incorporate 
a large fraction of the SARS-CoV-2 genetic variation at a global scale.
The WSP-based phylogenetic tree depicting all 593 SARS-CoV-2 haplotypes (Fig. 4) showed some geographi-
cal structure with two clusters: a smaller cluster comprising isolates mostly sampled from the Western Hemi-
sphere (Subtypes II and VI; tentative Subtypes IX, X and XI) and a larger cluster comprising isolates sampled 
from the Western and Eastern Hemispheres (Subtypes I, III, IV and V; tentative Subtypes VII, VIII, XII–XVI). 
The co-segregation of nucleotides at WSPs nsp3-[3,037], nsp12-[14,408] and S-[23,403] (Fig. 2) was responsible 
for the geographical structure in our ML tree (Fig. 4). The mutation nsp3U3,037C led to synonymous codons for 
phenylalanine in haplotypes from both clades, while the mutation nsp12U14,408C was non-synonymous, leading to 
leucine and proline in haplotypes from Western and Western/Eastern Hemisphere clades, respectively (Table 2). 
The  SG23,403A mutation led to non-synonymous codons for glycine and aspartate in haplotypes from Western and 
Table 2.  Unique genotypes of SARS-CoV-2 based on 12 WSPs and their associated amino acid replacements. 
a Sample size. bSegment containing the WSP. cNucleotide position relative to the reference genome (GISAID 
accession ID: EPI_ISL_402124). dNucleotide base and the encoded amino acid residue.
Subtypes Na
S2b S4 S6 S8 S10 S12 S14 S16
nsp3 nsp4 nsp6 nsp12 nsp13 nsp14 S ORF8 N
c3,037 c8,782 c11,083 c14,408 c17,747 c17,858 c18,060 c23,403 c28,144 c28,881 c28,882 c28,883
I 132 C [Phe]d C [Ser] G [Leu] C [Pro] C [Pro] A [Tyr] C [Leu] A [Asp] U [Leu] G [Arg] G [Arg] G [Arg]
II 122 U [Phe] C [Ser] G [Leu] U [Leu] C [Pro] A [Tyr] C [Leu] G [Gly] U [Leu] G [Arg] G [Arg] G [Arg]
III 101 C [Phe] U [Ser] G [Leu] C [Pro] U [Leu] G [Cys] U [Leu] A [Asp] C [Ser] G [Arg] G [Arg] G [Arg]
IV 91 C [Phe] C [Ser] U [Phe] C [Pro] C [Pro] A [Tyr] C [Leu] A [Asp] U [Leu] G [Arg] G [Arg] G [Arg]
V 74 C [Phe] U [Ser] G [Leu] C [Pro] C [Pro] A [Tyr] C [Leu] A [Asp] C [Ser] G [Arg] G [Arg] G [Arg]
VI 58 U [Phe] C [Ser] G [Leu] U [Leu] C [Pro] A [Tyr] C [Leu] G [Gly] U [Leu] A [Lys] A [Lys] C [Gly]
Tentative subtypes
VII 3 C [Phe] U [Ser] U [Phe] C [Pro] C [Pro] A [Tyr] C [Leu] A [Asp] C [Ser] G [Arg] G [Arg] G [Arg]
VIII 3 C [Phe] U [Ser] G [Leu] C [Pro] C [Pro] A [Tyr] U [Leu] A [Asp] C [Ser] G [Arg] G [Arg] G [Arg]
IX 2 U [Phe] C [Ser] U [Phe] U [Leu] C [Pro] A [Tyr] C [Leu] G [Gly] U [Leu] A [Lys] A [Lys] C [Gly]
X 1 U [Phe] C [Ser] U [Phe] U [Leu] C [Pro] A [Tyr] C [Leu] G [Gly] U [Leu] G [Arg] G [Arg] G [Arg]
XI 1 U [Phe] C [Ser] G [Leu] C [Pro] C [Pro] A [Tyr] C [Leu] G [Gly] U [Leu] G [Arg] G [Arg] G [Arg]
XII 1 C [Phe] C [Ser] G [Leu] C [Pro] C [Pro] A [Tyr] C [Leu] A [Asp] C [Ser] G [Arg] G [Arg] G [Arg]
XIII 1 C [Phe] U [Ser] G [Leu] C [Pro] C [Pro] A [Tyr] C [Leu] G [Gly] C [Ser] G [Arg] G [Arg] G [Arg]
XIV 1 C [Phe] C [Ser] U [Phe] U [Leu] C [Pro] A [Tyr] C [Leu] A [Asp] U [Leu] G [Arg] G [Arg] G [Arg]
XV 1 C [Phe] U [Ser] C [Phe] C [Pro] C [Pro] A [Tyr] C [Leu] A [Asp] C [Ser] G [Arg] G [Arg] G [Arg]
XVI 1 C [Phe] C [Ser] U [Phe] C [Pro] C [Pro] A [Tyr] U [Leu] A [Asp] U [Leu] G [Arg] G [Arg] G [Arg]
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Western/Eastern Hemisphere clades, respectively. Together, these results suggest the predominance of  NSP12L323 
and  SpikeG614 in the Western Hemisphere.
The WSP-based tree (Fig. 4) included only 12 nt sites, which represented 0.04% of the full-length multiple 
sequence alignment (29,412 nt after trimming the poor-quality 5′ and 3′ untranslated regions). Notably, the 
topologies of the WSP-based tree and the tree based on full-length genomes (Fig. S3) were highly similar, 
indicating a parsimonious approach for directly identifying the most informative sites in these viral genomes.
Virus barcoding and phylogenetic approaches have been conducted for SARS-CoV17 and Middle East respira-
tory syndrome coronavirus (MERS-CoV)18, respectively. Due to the limited geographical coverage of the MERS-
CoV epidemic, a study focusing on a region of Saudi Arabia tracked and distinguished two main genotypes 
of circulating MERS-CoV. On the other hand, 174 polymorphic loci in 101 complete genomes and 44 partial 
sequences of SARS-CoV allowed to further subdivide its population into two previously identified genotypes 
(named C and T)19 and an additional eight “subgenotypes” (C1–C4 and T1–T4) due to 10 special loci or informa-
tive  sites17. Interestingly, genotype C was compatible with the virus isolated during regional transmission and 
the early and intermediate phases of the SARS-CoV epidemic in the years 2003–2004, while genotype T was 
compatible with a viral type of international transmission from the late stage of virus  spread20,21. These results 
are similar to those of our study, which subdivided the genomes into major lineages of SARS-CoV-2. Therefore, 
the epidemic subdivisions of SARS-CoV and SARS-CoV-2 are apparent and similar because of possible viral 
adaptation as the virus spreads throughout the world.
Studies have been conducted to discriminate closely related bacterial taxa using Shannon entropy as a metric 
of sequence information  content22. A similar approach was recently applied to track the geographical and tem-
poral dynamics of SARS-CoV-223. In the latter study, analogous to our 12 WSP-based genotypes, 17 informative 
subtype markers (ISMs) were employed and revealed nine subtypes as the most represented in the overall virus 
population. All 12 WSPs detected in our study were identified as ISM sites, which indicates that nucleotide diver-
sity is also an informative metric with which to search for subtype signatures. Notably, the ISMs were proposed 
to track the virus spread within and between countries and/or continents, while our WSP-based approach was 
focused on highlighting the potential biological implications of such founding mutations since nine of 12 lead 
to non-synonymous replacements at the protein level.
It is important to note that the mutations at WSPs nsp13-[17,747 and 17,858] were responsible for the seg-
regation of Subtype III, that is, were redundant, and only one would be sufficient to reproduce the segregation 
into six major and 10 tentative subtypes. As a consequence, the set of WSPs necessary for subdivision identical 
to that shown in this study might be reduced to 11 nucleotide bases. However, we kept such informative sites 
according to the proposed threshold in our fine-scale genetic variation analyses, and they might be useful in a 
scenario where novel subtypes (partially similar to the genotype of Subtype III) are included due to the combined 
efforts of many countries to sequence thousands of SARS-CoV-2 genomes.
We hypothesize that our clustering method for the SARS-CoV-2 population could involve a biological context 
to some extent. The WSP nsp6-[11,083] in Subtype IV of SARS-CoV-2 led to phenylalanine at aa residue #37 of 
Figure 3.  Geographical distribution of six subtypes of SARS-CoV-2 around the world. The genomic data set 
comprised isolates sampled from 40 distinct countries from December 24, 2019 to March 20, 2020. The pie 
charts show the proportion of each subtype of SARS-CoV-2 according to a colour key in the figure bottom. For 
more detailed information on virus spread, a dynamic map is available at https ://micro react .org/proje ct/f25A3 
jAvE5 TjzxA f38UC Eq (accessible via the QR code in the bottom left corner of the map).
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the protein and leucine in five other subtypes (Table 2). NSP6 is an integral membrane protein that interferes with 
autophagosome formation during SARS-CoV infection. Additionally, in yeast two-hybrid  experiments24, NSP6 
has been shown to interact with NSP3. Some evidence demonstrates that NSP6 protein limits the expansion of 
autophagosomes or, alternatively, might remove host proteins involved in the inhibition of viral replication by 
activating autophagy from the  ER25.
The WSP nsp12-[14,408] resulted in proline in four subtypes of SARS-CoV-2 and leucine in two other sub-
types at aa residue #323 of the NSP12 (RNA-dependent RNA polymerase, RdRP) protein. This WSP is located 
at the interface domain of RdRP of SARS-CoV-2, which is responsible for the connection between the nidovirus 
RdRP-associated nucleotidyltransferase domain (NiRAN) and the “right hand” polymerase  domain26. The S pro-
tein mediates viral entry into host cells by first binding to a receptor, angiotensin-converting enzyme 2 (ACE2), 
through the receptor-binding domain (RBD) in the S1 subunit and then fusing the viral and host membranes 
through the S2  subunit27–30. Sites of glycosylation are important for S protein  folding31, affecting priming by host 
 proteases32 and might modulate antibody  recognition33,34. The WSP S-[23,403] resulted in glycine and aspartate 
at aa residue #614 of the S protein in two and four subtypes of SARS-CoV-2, respectively. The replacement 
Figure 4.  Maximum likelihood phylogenetic tree based on 12 WSPs detected across the SARS-CoV-2 genomes. 
The background colour of the tips indicates the subtype (I–VI) or tentative subtype (VII–XVI). An outer strip 
indicates the geographic origin (Western or Eastern Hemisphere) and whether each isolate was subjected to 
intermediate cell culture passages before genome sequencing.
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was mapped to the intermediate region between the S1 and S2 subunits. This WSP is near a glycosylation site 
(N616CT)35.
The WSP ORF8-[28,144] involved a non-synonymous mutation at codon #84 encoding leucine and serine 
in four and two subtypes, respectively. SARS-CoV ORF8 encodes an ER-associated protein that induces Activa-
tion of Transcription Factor 6 (ATF6), which is an ER stress-regulated transcription factor that stimulates the 
production of  chaperones36. The ORF8 protein has also been demonstrated to induce  apoptosis37. In the SARS 
epidemic, ORF8 was targeted by a number of mutations and recombination events during transmission from 
non-human animals to  humans38.
Three consecutive WSPs mapped in the N gene led to two amino acid replacements at residues #203 and #204. 
The multifunctional N protein is composed of three  domains39, two of which are structurally independent: the 
N-terminal domain (NTD) and the C-terminal domain (CTD). Both amino acid replacements were mapped to 
an intermediary domain referred to as the linker region (LKR), a positively charged serine-arginine-rich region. 
As an intrinsically disordered region (IDR), it allows the independent folding of the NTD and  CTD40 and is also 
functionally implicated in RNA binding  activity39. Key determinants of the interaction between the N and NSP3 
proteins were also mapped to the  LKR41. The SARS-CoV N protein is also responsible for an antigenic response 
in humans predominantly involving immunoglobulin  G42. Although the host biological factors involved in the 
response to SARS-CoV-2 infection are still poorly known, the existence of distinct virus subtypes, all of them 
exhibiting amino acid replacements, could affect important aspects of COVID-19.
We hypothesized that in the early stages of the SARS-CoV-2 epidemic, due to rapid virus population expan-
sion, a number of genetic variants might have arisen, followed by their spread to other countries and continents. 
We argue that the virus subtypes and their associated WSPs detected in this study could serve as records of 
diversification in these early stages of the epidemic after transmission from non-human animals to humans. After 
virus introduction to a given geographic region, a number of unique or narrowly shared mutations accumulate; 
however, most of them reduce fitness and are removed by purifying selection on a medium- to long-term evo-
lutionary scale, tending to decrease genetic  variability8.
Therefore, we propose classifying SARS-CoV-2 into at least six distinct subtypes accounting for more than 
97% of the isolates sampled from around the world. Such classification might guide the validation of candidate 
vaccines or drugs for the widest range of virus subtypes. In this context, our clustering solution provides a robust 
approach for effectively reducing the complexity of the mutant spectrum involving closely related SARS-CoV-2 
genomes and a focus on WSPs. Additionally, through exhaustive sequencing, it would be possible to change the 
tentative status of the ten genotypes described in this study or even identify novel virus subtypes and follow the 
evolutionary dynamics of the SARS-CoV-2 population during the adaptation process imposed by the human host.
Methods
A total of 1,137 full-length genomes of SARS-CoV-2 were obtained from  GenBank43 and  GISAID44 (Table S1) 
on March 25, 2020, and comprised virus isolates sampled from December 24, 2019, to March 20, 2020. Only 
genomes with high sequencing coverage, intact ORFs (no frameshifts, except that of the nsp12 cistron) and no 
indeterminate nucleotide bases (indicated by ‘N’s or ambiguous codes), totalling 767 high-quality full-length 
sequences, were effectively analysed in this study. We wish to acknowledge all researchers who deposited the 
SARS-CoV-2 genomes in the GISAID and/or GenBank database.
The genomic data set was aligned using MAFFT-FFT-NS-245. The calculation of the average number of 
nucleotide differences per site (nucleotide diversity, π) was conducted in DnaSP v.646 using sliding window and 
step sizes of 300 and 20 nucleotides, respectively. Sites with gap alignment were not considered in the analysis.
Maximum likelihood (ML) phylogenetic trees were constructed using  RAxML47 under the general time-
reversible with gamma distribution (GTRGAMMA) nucleotide substitution model. The branch support for 
ML trees based on 300 nucleotides and larger segments was assessed with 1000 and 5000 bootstrap replicates, 
respectively. The ML tree for full-length genomes was based on a multiple alignment whose 5′ and 3′ untranslated 
regions were trimmed. ML trees were used in this study essentially as a clustering method due to the weak phy-
logenetic signal in the data set. All phylogenetic trees were edited using  iTOL48. To assess the similarity among 
ML-tree topologies, we computed all possible pairwise distances by applying the Kendall–Colijn  metric49, fol-
lowed by principal coordinate analysis (PCoA), using the package  treespace50 in  R51.
The detection of polymorphic sites was conducted using PAUP* v. 4.052 and MEGA  X53. The sites responsible 
for the segregation of the isolates into two clusters in the ML trees were referred to as “widely shared polymor-
phisms” (WSPs), while the remaining nt positions in the virus genomes were designated as “non-widely shared 
polymorphisms” (nWSPs). The WSP positions were relative to the reference genome (GISAID accession ID: 
EPI_ISL_402124).
A Microreact project v70.0.0 was created for the metadata in a dynamic user  interface54. Interactive visualiza-
tion makes it possible to track virus sampling from a spatial–temporal perspective. A QR code for the interactive 
map was generated using the R package  qrcode55.
Data availability
The multiple sequence alignments and ML phylogenetic trees generated in this study are available from the 
authors upon request. The Microreact project is available at https ://micro react .org/proje ct/f25A3 jAvE5 TjzxA 
f38UC Eq.
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